

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.38953662 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.35468571 |
| 3 | actin-myosin filament sliding (GO:0033275) | 7.94626471 |
| 4 | muscle filament sliding (GO:0030049) | 7.94626471 |
| 5 | myofibril assembly (GO:0030239) | 7.86787363 |
| 6 | regulation of relaxation of muscle (GO:1901077) | 6.94286691 |
| 7 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.89588716 |
| 8 | creatine metabolic process (GO:0006600) | 6.82642764 |
| 9 | actin-mediated cell contraction (GO:0070252) | 6.71846528 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.69950184 |
| 11 | tricarboxylic acid cycle (GO:0006099) | 6.69720631 |
| 12 | cardiac muscle contraction (GO:0060048) | 6.57613870 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 6.57609856 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.49723844 |
| 15 | response to muscle activity (GO:0014850) | 6.48678614 |
| 16 | heart contraction (GO:0060047) | 6.28483222 |
| 17 | heart process (GO:0003015) | 6.28483222 |
| 18 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.23619596 |
| 19 | regulation of sarcomere organization (GO:0060297) | 6.19875387 |
| 20 | cardiac muscle cell development (GO:0055013) | 6.08016576 |
| 21 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.01472076 |
| 22 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.87309728 |
| 23 | regulation of actin filament-based movement (GO:1903115) | 5.82296500 |
| 24 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.80352253 |
| 25 | cardiac muscle hypertrophy (GO:0003300) | 5.76789805 |
| 26 | cardiac cell development (GO:0055006) | 5.74048499 |
| 27 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.73963930 |
| 28 | skeletal muscle fiber development (GO:0048741) | 5.65568506 |
| 29 | regulation of cell communication by electrical coupling (GO:0010649) | 5.62916495 |
| 30 | striated muscle contraction (GO:0006941) | 5.58898414 |
| 31 | actomyosin structure organization (GO:0031032) | 5.53274049 |
| 32 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.48536186 |
| 33 | striated muscle hypertrophy (GO:0014897) | 5.47313420 |
| 34 | carnitine shuttle (GO:0006853) | 5.36622467 |
| 35 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.29847460 |
| 36 | myotube cell development (GO:0014904) | 5.23577798 |
| 37 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.19499950 |
| 38 | muscle tissue morphogenesis (GO:0060415) | 5.15522744 |
| 39 | adult heart development (GO:0007512) | 5.10863827 |
| 40 | glycogen catabolic process (GO:0005980) | 5.01831778 |
| 41 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.95636180 |
| 42 | muscle hypertrophy (GO:0014896) | 4.95298555 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 4.93389063 |
| 44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.92986082 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.87876683 |
| 46 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.86941949 |
| 47 | actin filament-based movement (GO:0030048) | 4.83059155 |
| 48 | regulation of cofactor metabolic process (GO:0051193) | 4.80360948 |
| 49 | regulation of coenzyme metabolic process (GO:0051196) | 4.80360948 |
| 50 | oxidative phosphorylation (GO:0006119) | 4.78763441 |
| 51 | muscle fiber development (GO:0048747) | 4.76097145 |
| 52 | plasma membrane repair (GO:0001778) | 4.75217249 |
| 53 | fatty acid transmembrane transport (GO:1902001) | 4.71674213 |
| 54 | glucan catabolic process (GO:0009251) | 4.70588284 |
| 55 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.68902235 |
| 56 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.68514323 |
| 57 | heart trabecula formation (GO:0060347) | 4.61763980 |
| 58 | regulation of sequestering of triglyceride (GO:0010889) | 4.60140444 |
| 59 | glucan biosynthetic process (GO:0009250) | 4.58664456 |
| 60 | glycogen biosynthetic process (GO:0005978) | 4.58664456 |
| 61 | respiratory electron transport chain (GO:0022904) | 4.58508137 |
| 62 | skeletal muscle tissue development (GO:0007519) | 4.55368675 |
| 63 | electron transport chain (GO:0022900) | 4.44090629 |
| 64 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.43248287 |
| 65 | cellular polysaccharide catabolic process (GO:0044247) | 4.41804547 |
| 66 | skeletal muscle contraction (GO:0003009) | 4.38736471 |
| 67 | ATP synthesis coupled proton transport (GO:0015986) | 4.26507427 |
| 68 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.26507427 |
| 69 | regulation of the force of heart contraction (GO:0002026) | 4.22234774 |
| 70 | skeletal muscle tissue regeneration (GO:0043403) | 4.19344222 |
| 71 | muscle cell cellular homeostasis (GO:0046716) | 4.17000815 |
| 72 | regulation of membrane repolarization (GO:0060306) | 4.14035590 |
| 73 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.06045962 |
| 74 | muscle hypertrophy in response to stress (GO:0003299) | 4.06045962 |
| 75 | cardiac muscle adaptation (GO:0014887) | 4.06045962 |
| 76 | polysaccharide catabolic process (GO:0000272) | 3.97434511 |
| 77 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.96705936 |
| 78 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.96705936 |
| 79 | regulation of cardiac muscle contraction (GO:0055117) | 3.94396941 |
| 80 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.92989698 |
| 81 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.91360363 |
| 82 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.91360363 |
| 83 | carnitine transmembrane transport (GO:1902603) | 3.88989325 |
| 84 | NADH metabolic process (GO:0006734) | 3.84537126 |
| 85 | regulation of sulfur metabolic process (GO:0042762) | 3.82826525 |
| 86 | relaxation of cardiac muscle (GO:0055119) | 3.81334782 |
| 87 | striated muscle atrophy (GO:0014891) | 3.80464407 |
| 88 | muscle structure development (GO:0061061) | 3.78546430 |
| 89 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.77196127 |
| 90 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.77112330 |
| 91 | muscle organ development (GO:0007517) | 3.76020922 |
| 92 | muscle cell fate commitment (GO:0042693) | 3.71115732 |
| 93 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.70915864 |
| 94 | positive regulation of myotube differentiation (GO:0010831) | 3.70238156 |
| 95 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.70115164 |
| 96 | glycogen metabolic process (GO:0005977) | 3.67407303 |
| 97 | negative regulation of protein localization to cell surface (GO:2000009) | 3.66504094 |
| 98 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.65215465 |
| 99 | cardiac muscle cell action potential (GO:0086001) | 3.65125532 |
| 100 | muscle contraction (GO:0006936) | 3.64570867 |
| 101 | striated muscle cell development (GO:0055002) | 3.63218669 |
| 102 | regulation of heart rate (GO:0002027) | 3.62218137 |
| 103 | striated muscle adaptation (GO:0014888) | 3.62081907 |
| 104 | cell communication involved in cardiac conduction (GO:0086065) | 3.61483551 |
| 105 | glucan metabolic process (GO:0044042) | 3.59753938 |
| 106 | cellular glucan metabolic process (GO:0006073) | 3.59753938 |
| 107 | muscle adaptation (GO:0043500) | 3.58993381 |
| 108 | response to inactivity (GO:0014854) | 3.56595311 |
| 109 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.55657174 |
| 110 | quinone biosynthetic process (GO:1901663) | 3.55529914 |
| 111 | ubiquinone biosynthetic process (GO:0006744) | 3.55529914 |
| 112 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.50985343 |
| 113 | muscle system process (GO:0003012) | 3.47393560 |
| 114 | gluconeogenesis (GO:0006094) | 3.46742853 |
| 115 | carnitine transport (GO:0015879) | 3.45608084 |
| 116 | amino-acid betaine transport (GO:0015838) | 3.45608084 |
| 117 | cytidine deamination (GO:0009972) | 3.45401247 |
| 118 | cytidine metabolic process (GO:0046087) | 3.45401247 |
| 119 | cytidine catabolic process (GO:0006216) | 3.45401247 |
| 120 | muscle atrophy (GO:0014889) | 3.44037810 |
| 121 | relaxation of muscle (GO:0090075) | 3.43865335 |
| 122 | response to activity (GO:0014823) | 3.41817273 |
| 123 | regulation of ATPase activity (GO:0043462) | 3.41183472 |
| 124 | regulation of ATP catabolic process (GO:1903289) | 3.41183472 |
| 125 | positive regulation of cation channel activity (GO:2001259) | 3.40675320 |
| 126 | skeletal muscle adaptation (GO:0043501) | 3.40614039 |
| 127 | regulation of muscle contraction (GO:0006937) | 3.40264921 |
| 128 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39443746 |
| 129 | muscle cell development (GO:0055001) | 3.38799680 |
| 130 | regulation of myoblast differentiation (GO:0045661) | 3.36518745 |
| 131 | fructose metabolic process (GO:0006000) | 3.36495370 |
| 132 | regulation of muscle system process (GO:0090257) | 3.34717159 |
| 133 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.34283494 |
| 134 | cardiac chamber formation (GO:0003207) | 3.33840246 |
| 135 | cardiac conduction (GO:0061337) | 3.32584362 |
| 136 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.32466816 |
| 137 | fatty acid beta-oxidation (GO:0006635) | 3.32044687 |
| 138 | striated muscle tissue development (GO:0014706) | 3.29053193 |
| 139 | regulation of heart contraction (GO:0008016) | 3.28082419 |
| 140 | positive regulation of myoblast differentiation (GO:0045663) | 3.26626334 |
| 141 | succinate metabolic process (GO:0006105) | 3.26345272 |
| 142 | muscle organ morphogenesis (GO:0048644) | 3.25412562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.56562277 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.47984067 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.29990620 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.41624260 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.35197352 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.96646815 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.92318096 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.75700796 |
| 9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.75700796 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.62959257 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.42918746 |
| 12 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.11438388 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.07559624 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42443014 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.40677233 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.36382470 |
| 17 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.17258281 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10006601 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.97822507 |
| 20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86965740 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70380723 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69193082 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.62895741 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.62117701 |
| 25 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.58320522 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.55299182 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54061622 |
| 28 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.52512914 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50584866 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49531238 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.47869068 |
| 32 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.47166122 |
| 33 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.46931036 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43874479 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38153136 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34971272 |
| 37 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31138986 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21395939 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21115195 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18835373 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17261617 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17045603 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15213756 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.14573864 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14398022 |
| 46 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14272089 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13804876 |
| 48 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.13736336 |
| 49 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12903839 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08981358 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08830861 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08084244 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.06418404 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.05882497 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05718133 |
| 56 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.05634625 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05388692 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04354582 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02243853 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02175569 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02024042 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01010037 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99702630 |
| 64 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98922531 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98631450 |
| 66 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.98421197 |
| 67 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95724334 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95373569 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95100968 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94986984 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94145115 |
| 72 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93399044 |
| 73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92891963 |
| 74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92093844 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92085366 |
| 76 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89810027 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89662362 |
| 78 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.89549824 |
| 79 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88769831 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88289576 |
| 81 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88096976 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88017113 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88017113 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87646783 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87624344 |
| 86 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.87397453 |
| 87 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.87374977 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87313085 |
| 89 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.85453369 |
| 90 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.85392015 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.84700229 |
| 92 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84172907 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83971023 |
| 94 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82910783 |
| 95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82910783 |
| 96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82010340 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81708294 |
| 98 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.81505447 |
| 99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81099739 |
| 100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80363155 |
| 101 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.79130423 |
| 102 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78941419 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78326052 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78050558 |
| 105 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.77986281 |
| 106 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77967783 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77868337 |
| 108 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.77536306 |
| 109 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77383869 |
| 110 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77217563 |
| 111 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.77109357 |
| 112 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77052876 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.76675202 |
| 114 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.76549234 |
| 115 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.76487830 |
| 116 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.75951706 |
| 117 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.75940893 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.75878146 |
| 119 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.75818849 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75797506 |
| 121 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.74972491 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.74862102 |
| 123 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.74862102 |
| 124 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.74747799 |
| 125 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.74742788 |
| 126 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.74518968 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73850618 |
| 128 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73712027 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73461018 |
| 130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.73415724 |
| 131 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.73312198 |
| 132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.71342570 |
| 133 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.70964040 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70962489 |
| 135 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.70935806 |
| 136 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.70363576 |
| 137 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70187456 |
| 138 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.70025433 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.69248763 |
| 140 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.69175823 |
| 141 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.69119520 |
| 142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68763656 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68491023 |
| 144 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68091089 |
| 145 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.67641833 |
| 146 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.67555451 |
| 147 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.66499816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.81854992 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.81483830 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.46495371 |
| 4 | MP0000751_myopathy | 4.70400122 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.67283924 |
| 6 | MP0000749_muscle_degeneration | 4.64305008 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.30285113 |
| 8 | MP0005330_cardiomyopathy | 3.86258003 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.27761450 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.08063847 |
| 11 | MP0005620_abnormal_muscle_contractility | 2.95863658 |
| 12 | MP0004130_abnormal_muscle_cell | 2.94371947 |
| 13 | MP0008775_abnormal_heart_ventricle | 2.89990761 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.87962750 |
| 15 | MP0003137_abnormal_impulse_conducting | 2.74418172 |
| 16 | MP0004484_altered_response_of | 2.73640941 |
| 17 | MP0002106_abnormal_muscle_physiology | 2.71569675 |
| 18 | MP0001544_abnormal_cardiovascular_syste | 2.64228345 |
| 19 | MP0005385_cardiovascular_system_phenoty | 2.64228345 |
| 20 | MP0003828_pulmonary_edema | 2.56220076 |
| 21 | MP0010630_abnormal_cardiac_muscle | 2.55385180 |
| 22 | MP0000750_abnormal_muscle_regeneration | 2.39686393 |
| 23 | MP0006138_congestive_heart_failure | 2.34152108 |
| 24 | MP0005670_abnormal_white_adipose | 2.29918487 |
| 25 | MP0002269_muscular_atrophy | 2.26143843 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 2.22908523 |
| 27 | MP0005369_muscle_phenotype | 2.21667593 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 2.11121622 |
| 29 | MP0000759_abnormal_skeletal_muscle | 2.07891722 |
| 30 | MP0002127_abnormal_cardiovascular_syste | 2.06258445 |
| 31 | MP0004510_myositis | 1.97230758 |
| 32 | MP0004085_abnormal_heartbeat | 1.95734099 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.87234136 |
| 34 | MP0000747_muscle_weakness | 1.85166591 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.59453732 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.52457689 |
| 37 | MP0004270_analgesia | 1.45145800 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.43667668 |
| 39 | MP0004233_abnormal_muscle_weight | 1.39012673 |
| 40 | MP0000343_altered_response_to | 1.35518415 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.22335577 |
| 42 | MP0004147_increased_porphyrin_level | 1.19926734 |
| 43 | MP0000266_abnormal_heart_morphology | 1.11652463 |
| 44 | MP0005165_increased_susceptibility_to | 1.09487737 |
| 45 | MP0001661_extended_life_span | 1.06162795 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.03381831 |
| 47 | MP0005451_abnormal_body_composition | 0.98640952 |
| 48 | MP0005375_adipose_tissue_phenotype | 0.98239064 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 0.97815462 |
| 50 | MP0002822_catalepsy | 0.97198634 |
| 51 | MP0002108_abnormal_muscle_morphology | 0.91104911 |
| 52 | MP0003279_aneurysm | 0.86209180 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 0.85430336 |
| 54 | MP0005266_abnormal_metabolism | 0.81747006 |
| 55 | MP0000372_irregular_coat_pigmentation | 0.79992438 |
| 56 | MP0002971_abnormal_brown_adipose | 0.78101230 |
| 57 | MP0000230_abnormal_systemic_arterial | 0.77594526 |
| 58 | MP0002234_abnormal_pharynx_morphology | 0.74792704 |
| 59 | MP0002128_abnormal_blood_circulation | 0.71531500 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 0.69484486 |
| 61 | MP0003045_fibrosis | 0.64379713 |
| 62 | MP0000767_abnormal_smooth_muscle | 0.59383709 |
| 63 | MP0000733_abnormal_muscle_development | 0.58427634 |
| 64 | MP0004142_abnormal_muscle_tone | 0.55114726 |
| 65 | MP0004134_abnormal_chest_morphology | 0.54751930 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.52983718 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.52789989 |
| 68 | MP0003186_abnormal_redox_activity | 0.51896108 |
| 69 | MP0008569_lethality_at_weaning | 0.51633866 |
| 70 | MP0000003_abnormal_adipose_tissue | 0.51000056 |
| 71 | MP0001299_abnormal_eye_distance/ | 0.50188304 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.49569151 |
| 73 | MP0005334_abnormal_fat_pad | 0.49058090 |
| 74 | MP0003879_abnormal_hair_cell | 0.47974024 |
| 75 | MP0005171_absent_coat_pigmentation | 0.47605314 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.45025960 |
| 77 | MP0009697_abnormal_copulation | 0.44801459 |
| 78 | MP0009115_abnormal_fat_cell | 0.43020081 |
| 79 | MP0003941_abnormal_skin_development | 0.42936167 |
| 80 | MP0004043_abnormal_pH_regulation | 0.41406145 |
| 81 | MP0005535_abnormal_body_temperature | 0.38919042 |
| 82 | MP0002925_abnormal_cardiovascular_devel | 0.36842473 |
| 83 | MP0003984_embryonic_growth_retardation | 0.34598654 |
| 84 | MP0003948_abnormal_gas_homeostasis | 0.34571570 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.33519198 |
| 86 | MP0001784_abnormal_fluid_regulation | 0.33321106 |
| 87 | MP0009672_abnormal_birth_weight | 0.33284548 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.33247517 |
| 89 | MP0005187_abnormal_penis_morphology | 0.32986547 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 0.31860771 |
| 91 | MP0001984_abnormal_olfaction | 0.31792169 |
| 92 | MP0001614_abnormal_blood_vessel | 0.31200925 |
| 93 | MP0001853_heart_inflammation | 0.30620123 |
| 94 | MP0005332_abnormal_amino_acid | 0.30397966 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.29036624 |
| 96 | MP0003136_yellow_coat_color | 0.28296739 |
| 97 | MP0004272_abnormal_basement_membrane | 0.27966827 |
| 98 | MP0002114_abnormal_axial_skeleton | 0.27622979 |
| 99 | MP0000762_abnormal_tongue_morphology | 0.27014417 |
| 100 | MP0009250_abnormal_appendicular_skeleto | 0.26805160 |
| 101 | MP0005377_hearing/vestibular/ear_phenot | 0.26482662 |
| 102 | MP0003878_abnormal_ear_physiology | 0.26482662 |
| 103 | MP0005595_abnormal_vascular_smooth | 0.25476876 |
| 104 | MP0005388_respiratory_system_phenotype | 0.25267799 |
| 105 | MP0002133_abnormal_respiratory_system | 0.25267799 |
| 106 | MP0005166_decreased_susceptibility_to | 0.25130661 |
| 107 | MP0005452_abnormal_adipose_tissue | 0.25077302 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.24920217 |
| 109 | MP0000516_abnormal_urinary_system | 0.23821095 |
| 110 | MP0005367_renal/urinary_system_phenotyp | 0.23821095 |
| 111 | MP0001943_abnormal_respiration | 0.23469829 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.23446245 |
| 113 | MP0002066_abnormal_motor_capabilities/c | 0.23390151 |
| 114 | MP0003195_calcinosis | 0.23182978 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.22246821 |
| 116 | MP0005083_abnormal_biliary_tract | 0.21709200 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.21563038 |
| 118 | MP0004924_abnormal_behavior | 0.21563038 |
| 119 | MP0006276_abnormal_autonomic_nervous | 0.21447925 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.21419500 |
| 121 | MP0010030_abnormal_orbit_morphology | 0.20722512 |
| 122 | MP0001346_abnormal_lacrimal_gland | 0.20278018 |
| 123 | MP0003806_abnormal_nucleotide_metabolis | 0.19815253 |
| 124 | MP0005423_abnormal_somatic_nervous | 0.19170892 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.19050031 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.18814774 |
| 127 | MP0000249_abnormal_blood_vessel | 0.18811177 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.18726671 |
| 129 | MP0002970_abnormal_white_adipose | 0.17235434 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.16700966 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.14333479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.08071563 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.80060341 |
| 3 | Ventricular tachycardia (HP:0004756) | 6.41512492 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.38943667 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.36008203 |
| 6 | Distal arthrogryposis (HP:0005684) | 6.24982250 |
| 7 | Exercise-induced myalgia (HP:0003738) | 6.17570580 |
| 8 | Atrial fibrillation (HP:0005110) | 5.76541873 |
| 9 | Myopathic facies (HP:0002058) | 5.34299438 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 5.32994523 |
| 11 | Myoglobinuria (HP:0002913) | 5.23908991 |
| 12 | Subaortic stenosis (HP:0001682) | 5.22722134 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.22722134 |
| 14 | Lipoatrophy (HP:0100578) | 5.22030485 |
| 15 | Supraventricular tachycardia (HP:0004755) | 5.17277633 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 5.11146540 |
| 17 | Round ear (HP:0100830) | 5.05220924 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 5.04145486 |
| 19 | Muscle fiber splitting (HP:0003555) | 4.79789238 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 4.70109969 |
| 21 | Dilated cardiomyopathy (HP:0001644) | 4.48354666 |
| 22 | Syncope (HP:0001279) | 4.38051642 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 4.21193213 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 4.20196388 |
| 25 | Palpitations (HP:0001962) | 4.16952866 |
| 26 | Calcaneovalgus deformity (HP:0001848) | 4.10670325 |
| 27 | Rhabdomyolysis (HP:0003201) | 4.08108374 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 4.04405561 |
| 29 | Prolonged QT interval (HP:0001657) | 3.95305681 |
| 30 | Bundle branch block (HP:0011710) | 3.92592121 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 3.85247404 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84860626 |
| 33 | Absent phalangeal crease (HP:0006109) | 3.70398850 |
| 34 | Ventricular arrhythmia (HP:0004308) | 3.67519651 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.63968221 |
| 36 | Deformed tarsal bones (HP:0008119) | 3.63111572 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 3.55684838 |
| 38 | Hepatic necrosis (HP:0002605) | 3.50277563 |
| 39 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.48249442 |
| 40 | Heart block (HP:0012722) | 3.45049714 |
| 41 | Frequent falls (HP:0002359) | 3.37305030 |
| 42 | Increased connective tissue (HP:0009025) | 3.27951813 |
| 43 | EMG: neuropathic changes (HP:0003445) | 3.24249601 |
| 44 | Abnormal atrioventricular conduction (HP:0005150) | 3.22872040 |
| 45 | Acute encephalopathy (HP:0006846) | 3.21132876 |
| 46 | Progressive macrocephaly (HP:0004481) | 3.16487865 |
| 47 | Malignant hyperthermia (HP:0002047) | 3.07704721 |
| 48 | Abnormal finger flexion creases (HP:0006143) | 3.07459361 |
| 49 | Myotonia (HP:0002486) | 3.06630792 |
| 50 | Nemaline bodies (HP:0003798) | 3.05885449 |
| 51 | Mitochondrial inheritance (HP:0001427) | 3.04021268 |
| 52 | Atrioventricular block (HP:0001678) | 3.03805240 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 3.02310163 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.99863800 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.99863800 |
| 56 | Hyperalaninemia (HP:0003348) | 2.99863800 |
| 57 | Difficulty running (HP:0009046) | 2.97384102 |
| 58 | Exercise intolerance (HP:0003546) | 2.95489290 |
| 59 | Abnormal EKG (HP:0003115) | 2.95339405 |
| 60 | Increased CSF lactate (HP:0002490) | 2.94537127 |
| 61 | Hepatocellular necrosis (HP:0001404) | 2.92079396 |
| 62 | Type 1 muscle fiber predominance (HP:0003803) | 2.91713086 |
| 63 | Left ventricular hypertrophy (HP:0001712) | 2.90504326 |
| 64 | Hypoglycemic coma (HP:0001325) | 2.89245805 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82093641 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.82093641 |
| 67 | Muscle stiffness (HP:0003552) | 2.76929581 |
| 68 | Fetal akinesia sequence (HP:0001989) | 2.76921718 |
| 69 | Ventricular fibrillation (HP:0001663) | 2.76492378 |
| 70 | Cerebral edema (HP:0002181) | 2.74781756 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.67045885 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.62076003 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.59940347 |
| 74 | Neck muscle weakness (HP:0000467) | 2.58902268 |
| 75 | Areflexia of lower limbs (HP:0002522) | 2.57241566 |
| 76 | Lactic acidosis (HP:0003128) | 2.54111588 |
| 77 | Gowers sign (HP:0003391) | 2.48194836 |
| 78 | Bulbar palsy (HP:0001283) | 2.45590252 |
| 79 | Palmoplantar keratoderma (HP:0000982) | 2.45177966 |
| 80 | Distal lower limb amyotrophy (HP:0008944) | 2.43995133 |
| 81 | Weak cry (HP:0001612) | 2.41345075 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.37587771 |
| 83 | Progressive muscle weakness (HP:0003323) | 2.36417658 |
| 84 | Scapular winging (HP:0003691) | 2.35769404 |
| 85 | Slender build (HP:0001533) | 2.35360837 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.29992429 |
| 87 | Rimmed vacuoles (HP:0003805) | 2.29514122 |
| 88 | Abnormality of the calcaneus (HP:0008364) | 2.29289293 |
| 89 | Generalized muscle weakness (HP:0003324) | 2.28977051 |
| 90 | Respiratory failure (HP:0002878) | 2.27607130 |
| 91 | Ketoacidosis (HP:0001993) | 2.26619699 |
| 92 | Hip contracture (HP:0003273) | 2.23233150 |
| 93 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.22131428 |
| 94 | Fatigable weakness (HP:0003473) | 2.21670976 |
| 95 | Abnormality of the neuromuscular junction (HP:0003398) | 2.21670976 |
| 96 | Difficulty climbing stairs (HP:0003551) | 2.20584954 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 2.17395528 |
| 98 | Ragged-red muscle fibers (HP:0003200) | 2.15964436 |
| 99 | Renal cortical cysts (HP:0000803) | 2.15265494 |
| 100 | Abnormality of the foot musculature (HP:0001436) | 2.15257934 |
| 101 | Hyperkalemia (HP:0002153) | 2.12168657 |
| 102 | Conjunctival hamartoma (HP:0100780) | 2.11262521 |
| 103 | Nausea (HP:0002018) | 2.10781771 |
| 104 | Lipid accumulation in hepatocytes (HP:0006561) | 2.09368557 |
| 105 | Neuroendocrine neoplasm (HP:0100634) | 2.09126148 |
| 106 | Neoplasm of the adrenal gland (HP:0100631) | 2.09096818 |
| 107 | Congenital malformation of the right heart (HP:0011723) | 2.05050114 |
| 108 | Double outlet right ventricle (HP:0001719) | 2.05050114 |
| 109 | Proximal amyotrophy (HP:0007126) | 2.04738393 |
| 110 | Neoplasm of head and neck (HP:0012288) | 2.04648485 |
| 111 | Esophageal neoplasm (HP:0100751) | 2.04648485 |
| 112 | Spinal rigidity (HP:0003306) | 2.00924057 |
| 113 | Pheochromocytoma (HP:0002666) | 1.99291872 |
| 114 | Increased serum pyruvate (HP:0003542) | 1.98995355 |
| 115 | Abnormality of glycolysis (HP:0004366) | 1.98995355 |
| 116 | Waddling gait (HP:0002515) | 1.97115419 |
| 117 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96789789 |
| 118 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96379351 |
| 119 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96379351 |
| 120 | Foot dorsiflexor weakness (HP:0009027) | 1.93642633 |
| 121 | Muscular dystrophy (HP:0003560) | 1.92571207 |
| 122 | Facial diplegia (HP:0001349) | 1.92091571 |
| 123 | Limb-girdle muscle atrophy (HP:0003797) | 1.91473015 |
| 124 | Congestive heart failure (HP:0001635) | 1.90135356 |
| 125 | Lower limb amyotrophy (HP:0007210) | 1.89617253 |
| 126 | Testicular atrophy (HP:0000029) | 1.89068404 |
| 127 | Increased serum lactate (HP:0002151) | 1.88918459 |
| 128 | Tinnitus (HP:0000360) | 1.88711245 |
| 129 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86966572 |
| 130 | Hypoplastic left heart (HP:0004383) | 1.86412763 |
| 131 | Proximal tubulopathy (HP:0000114) | 1.84219245 |
| 132 | Toxemia of pregnancy (HP:0100603) | 1.83677008 |
| 133 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.82849214 |
| 134 | Popliteal pterygium (HP:0009756) | 1.82582868 |
| 135 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.78178784 |
| 136 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.78178784 |
| 137 | Metatarsus adductus (HP:0001840) | 1.74556372 |
| 138 | Long clavicles (HP:0000890) | 1.70849307 |
| 139 | Limb-girdle muscle weakness (HP:0003325) | 1.67994435 |
| 140 | Shoulder girdle muscle weakness (HP:0003547) | 1.66340357 |
| 141 | Type 2 muscle fiber atrophy (HP:0003554) | 1.66309715 |
| 142 | Pelvic girdle muscle weakness (HP:0003749) | 1.64172562 |
| 143 | Ulnar deviation of finger (HP:0009465) | 1.59977561 |
| 144 | Steppage gait (HP:0003376) | 1.54782199 |
| 145 | Nonprogressive disorder (HP:0003680) | 1.51259030 |
| 146 | Muscle fiber atrophy (HP:0100295) | 1.50024949 |
| 147 | Oligomenorrhea (HP:0000876) | 1.49820014 |
| 148 | Limited hip movement (HP:0008800) | 1.48969945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.17095127 |
| 2 | TTN | 4.77143765 |
| 3 | MYLK | 3.58171453 |
| 4 | PHKG2 | 3.43746700 |
| 5 | PHKG1 | 3.43746700 |
| 6 | STK24 | 3.09587122 |
| 7 | PDK3 | 3.06263230 |
| 8 | PDK4 | 3.06263230 |
| 9 | TIE1 | 2.73125225 |
| 10 | ZAK | 2.62661665 |
| 11 | PIK3CA | 2.57512158 |
| 12 | LMTK2 | 2.52621356 |
| 13 | BCKDK | 2.34919984 |
| 14 | MUSK | 2.28435394 |
| 15 | STK16 | 2.26507827 |
| 16 | PINK1 | 2.24552493 |
| 17 | DMPK | 2.19824840 |
| 18 | PDK2 | 2.01950315 |
| 19 | PKN2 | 2.00132109 |
| 20 | GRK7 | 1.99058994 |
| 21 | STK38L | 1.85017058 |
| 22 | NEK1 | 1.71475017 |
| 23 | TRPM7 | 1.56271531 |
| 24 | INSRR | 1.43678340 |
| 25 | NEK9 | 1.33990119 |
| 26 | PRKAA2 | 1.21347913 |
| 27 | MARK1 | 1.20853827 |
| 28 | FLT3 | 1.20663923 |
| 29 | MAP2K4 | 1.15335508 |
| 30 | LIMK1 | 1.14685764 |
| 31 | STK4 | 1.07840211 |
| 32 | MAP3K7 | 1.06071872 |
| 33 | PIK3CG | 1.05934361 |
| 34 | CAMK2D | 1.00671501 |
| 35 | MAPK12 | 1.00029360 |
| 36 | CDC42BPA | 0.97580260 |
| 37 | PRKAA1 | 0.96287685 |
| 38 | PRPF4B | 0.93489715 |
| 39 | IRAK3 | 0.89687404 |
| 40 | ILK | 0.89126773 |
| 41 | TRIB3 | 0.84387860 |
| 42 | PRKD1 | 0.83396969 |
| 43 | MAP2K3 | 0.83255357 |
| 44 | EEF2K | 0.82685930 |
| 45 | TGFBR2 | 0.80597183 |
| 46 | DYRK1B | 0.78548272 |
| 47 | CAMK4 | 0.77727869 |
| 48 | MOS | 0.73764296 |
| 49 | NME2 | 0.72231901 |
| 50 | RIPK1 | 0.68784865 |
| 51 | TXK | 0.65828387 |
| 52 | PAK3 | 0.64946497 |
| 53 | CAMK1 | 0.61256611 |
| 54 | RPS6KL1 | 0.60555269 |
| 55 | RPS6KC1 | 0.60555269 |
| 56 | ERBB3 | 0.60483535 |
| 57 | ROCK1 | 0.59106912 |
| 58 | SGK2 | 0.56412688 |
| 59 | PKN1 | 0.56198488 |
| 60 | RPS6KA6 | 0.56191897 |
| 61 | LATS1 | 0.56111389 |
| 62 | IRAK4 | 0.55626040 |
| 63 | MAP3K14 | 0.55440403 |
| 64 | MAP3K5 | 0.54945747 |
| 65 | NME1 | 0.53703080 |
| 66 | MAPK4 | 0.49292083 |
| 67 | EIF2AK2 | 0.48290077 |
| 68 | MAP2K1 | 0.47578184 |
| 69 | PRKCE | 0.46825566 |
| 70 | MAP3K13 | 0.46384476 |
| 71 | CAMK2B | 0.46210256 |
| 72 | NUAK1 | 0.45154391 |
| 73 | AKT2 | 0.44074280 |
| 74 | CAMK2A | 0.42801531 |
| 75 | MAP3K3 | 0.41047894 |
| 76 | PRKACA | 0.40206950 |
| 77 | PRKACB | 0.39926065 |
| 78 | KSR2 | 0.39492095 |
| 79 | MAPKAPK3 | 0.38944411 |
| 80 | TEC | 0.38842872 |
| 81 | CAMK1D | 0.38289373 |
| 82 | MAPK7 | 0.36965688 |
| 83 | DAPK3 | 0.35846694 |
| 84 | SGK3 | 0.34626845 |
| 85 | MAPK11 | 0.32515186 |
| 86 | TAOK2 | 0.31613002 |
| 87 | SGK1 | 0.29846088 |
| 88 | MAPK13 | 0.29570554 |
| 89 | PRKG1 | 0.29477687 |
| 90 | PRKACG | 0.29112568 |
| 91 | STK38 | 0.29042551 |
| 92 | JAK1 | 0.28862663 |
| 93 | RPS6KA3 | 0.28648033 |
| 94 | WNK4 | 0.26997879 |
| 95 | WNK1 | 0.24359799 |
| 96 | LATS2 | 0.23719358 |
| 97 | CAMK2G | 0.22411787 |
| 98 | PRKCQ | 0.22214097 |
| 99 | CCNB1 | 0.21212472 |
| 100 | MAPK10 | 0.21173980 |
| 101 | KDR | 0.20620723 |
| 102 | RPS6KB1 | 0.20383195 |
| 103 | TBK1 | 0.19711544 |
| 104 | RPS6KB2 | 0.19462789 |
| 105 | STK3 | 0.18821001 |
| 106 | DAPK2 | 0.18400964 |
| 107 | MARK3 | 0.18226197 |
| 108 | ADRBK2 | 0.16992426 |
| 109 | STK11 | 0.16601187 |
| 110 | KIT | 0.15893103 |
| 111 | MAP3K6 | 0.15362349 |
| 112 | MAP3K1 | 0.15113265 |
| 113 | RPS6KA1 | 0.14729216 |
| 114 | ICK | 0.14104544 |
| 115 | MAP2K6 | 0.13440911 |
| 116 | AKT1 | 0.13372585 |
| 117 | BRSK2 | 0.13196752 |
| 118 | PTK2B | 0.13003760 |
| 119 | RPS6KA2 | 0.12404780 |
| 120 | JAK3 | 0.11182108 |
| 121 | EPHA3 | 0.11179404 |
| 122 | MAP3K4 | 0.11067001 |
| 123 | MAP4K1 | 0.11045464 |
| 124 | PDK1 | 0.10894470 |
| 125 | MAPK15 | 0.10871253 |
| 126 | BMPR1B | 0.10798222 |
| 127 | MAP3K10 | 0.10611237 |
| 128 | TNIK | 0.09948505 |
| 129 | ZAP70 | 0.09842162 |
| 130 | FGFR3 | 0.08914669 |
| 131 | CDK19 | 0.08700250 |
| 132 | PDPK1 | 0.08630653 |
| 133 | SGK223 | 0.08539828 |
| 134 | SGK494 | 0.08539828 |
| 135 | KSR1 | 0.08403652 |
| 136 | RAF1 | 0.08108643 |
| 137 | MARK2 | 0.07530746 |
| 138 | MTOR | 0.06930490 |
| 139 | NLK | 0.05556335 |
| 140 | EPHB1 | 0.04769598 |
| 141 | ROCK2 | 0.02216868 |
| 142 | MAPK9 | 0.01944068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.41402122 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.39151790 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.98529413 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.70989784 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.70715087 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.69147430 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.58828064 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.57759160 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.96765256 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 2.61975106 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.56024516 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.47553916 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46075043 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.41296674 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.40863129 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.21217496 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81265411 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67645400 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60167334 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57553329 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49426182 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43179944 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38621124 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26062953 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20893060 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.14899067 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08699010 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07303930 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05402461 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02428410 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.01562098 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98096542 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 0.96870366 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96209449 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.93347898 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92759429 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91317012 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84295592 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84002465 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83112244 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82340255 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 0.80865352 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79950209 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76913528 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70550891 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69512246 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67275393 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 0.66347908 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65568017 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63941285 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62995428 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62910330 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62674637 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61778631 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56382463 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51966688 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50375290 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47663161 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 0.45488838 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45435698 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44699895 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43516856 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43446181 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42823175 |
| 65 | Focal adhesion_Homo sapiens_hsa04510 | 0.42191502 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36630548 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34859455 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34303770 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32772307 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.32117515 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31950088 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.30974022 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28966048 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28295089 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28234447 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27969308 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.26534568 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.26502808 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25835723 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25427375 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21999970 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21281466 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21052743 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.17980826 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17973677 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.17824504 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.17191335 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17144435 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.15900670 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.15059220 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14587664 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.13899083 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13228954 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.13151324 |
| 95 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.13053377 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.12781836 |
| 97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.12649416 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11682260 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11437724 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.11124499 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.11077063 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10667587 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.10447568 |
| 104 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.10014034 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.09763847 |
| 106 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.09664160 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08696515 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.08391854 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.08060273 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.06370879 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.06184496 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.05681483 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05648525 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.05625193 |
| 115 | Homologous recombination_Homo sapiens_hsa03440 | 0.04729338 |
| 116 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.02381597 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01149985 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.00983519 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.00766947 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.00142252 |
| 121 | Arginine biosynthesis_Homo sapiens_hsa00220 | -0.0587500 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0574105 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | -0.0561777 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0526488 |
| 125 | Allograft rejection_Homo sapiens_hsa05330 | -0.0524680 |
| 126 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0501812 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | -0.0370844 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.0343469 |
| 129 | Measles_Homo sapiens_hsa05162 | -0.0265874 |
| 130 | Circadian entrainment_Homo sapiens_hsa04713 | -0.0225369 |

